Author | Hans-Joachim Lück, MD

Articles

UFT/Leucovorin Combined With Paclitaxel for Anthracycline-Pretreated Advanced Breast Cancer

October 01, 2000

Taxanes are the most active drugs in the treatment of metastatic breast and ovarian cancer. Weekly therapy with paclitaxel produces notable activity, with remarkably low toxicity.

UFT/Oral Calcium Folinate Plus Weekly Paclitaxel for Metastatic Breast Cancer

July 01, 1999

Paclitaxel (Taxol) is one of the most active drugs in the treatment of ovarian and breast cancers. Combination therapy with paclitaxel and 5-fluorouracil (5-FU) exhibits high activity in anthracycline-pretreated breast cancer,

Metastatic Breast Cancer: Experience with the Combination Paclitaxel Plus Epirubicin

January 01, 1998

This study evaluated the safety and feasibility of the combination of paclitaxel (Taxol) and epirubicin, the 4¢-epimer of doxorubicin, in women with metastatic breast cancer. A total of 85 patients with histologically proven

Paclitaxel and Epirubicin as First-Line Therapy for Patients With Metastatic Breast Cancer

April 01, 1997

Paclitaxel (Taxol) has aroused considerable interest for its high single-agent activity in breast cancer and novel mechanism of action. Epirubicin (Farmorubicin), the 4'epimer of doxorubicin (Adriamycin), also has high activity in